MIT Deshpande Centre awards research grants

Published: 13-Oct-2011
Research & Development Finance

Eight research teams receive US$668,000 to develop technological innovations


The Deshpande Centre for Technological Innovation at MIT in Cambridge, MA, US is awarding US$668,000 in grants to eight MIT research teams currently working on early-stage technologies.

These projects have the potential to make a significant impact on quality of life by revolutionising materials, diagnostics, medical procedures, diabetes treatment, vision correction, high power electronics, solar energy efficiency, and software support.

The autumn 2011 grant recipients will use the funding in research projects to develop:

  • An ultrasound pill for localised delivery of therapeutic compounds
  • An on-chip diagnostic device
  • MEMS for large area and flexible applications
  • A low cost solvent extraction process to treat water
  • An intra-peritoneal implantable drug delivery device for ovarian cancer
  • Tissue-specific adhesive materials
  • Real-time component-based simulations for design
  • Nano-engineered surfaces for ultra high power density thermal management heat from such devices

‘We continue to be impressed by the creativity and ingenuity of our grantees,’ said Leon Sandler, executive director of the Deshpande Centre.

‘Their technologies could have a significant impact in health care, energy, materials and design.’

The Deshpande Centre’s mission is to move technologies from the laboratories at MIT to the marketplace. The grants help recipients assess and reduce the technical and market risks associated with their innovations.

In addition to financial support, the Deshpande Centre’s network of entrepreneurs, venture capitalists, and academic and legal experts helps recipients assess the commercial potential of their innovations and make decisions that accelerate progress toward the development of business plans or licensing strategies.

The Deshpande Centre has provided approximately $11m in grants to more than 90 MIT research projects since 2002. Twenty six projects have spun out of the center as independent start-ups, having collectively raised more than US$350m in financing from investors.

See more

You may also like

Manufacturing

MIT researchers to lead a new centre for continuous mRNA manufacturing

Read more
Faculty at the MIT are embarking upon a three-year research programme to design the world's first fully integrated, continuous mRNA manufacturing platform

Trending Articles

  1. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste
  2. Almac expands bioavailability capabilities to address a critical need in drug development Almac Group has completed a multimillion-pound expansion of its bioavailability enhancement capabilities at its facility in Charnwood, UK
  3. Servier acquires potential treatment for Fragile X syndrome KER-0193, a novel, orally bioavailable small molecule, was granted orphan drug and rare paediatric drug designation by the US FDA
  4. NICE recommends enfortumab vedotin with KEYTRUDA for adults in England/Wales with untreated metastatic urothelial cancer The results from the Phase III study EV-302/KN-A39 showed nearly a doubling of survival rates in patients compared with those who received platinum-based chemotherapy, which is the current standard of care in the UK
  5. Fidia Farmaceutici enters the UK market with the acquisition of Altacor Marking another significant milestone in its ongoing international expansion, the company enters the rapidly growing UK ophthalmology market, a key therapeutic area for the group

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

MIT researchers to lead a new centre for continuous mRNA manufacturing

Faculty at the MIT are embarking upon a three-year research programme to design the world's first fully integrated, continuous mRNA manufacturing platform
Research & Development

Novo Nordisk and MIT extend oral delivery tech collaboration

Since 2015, the industry-academia venture has explored alternatives to syringe and pen-based delivery of biologics
Research & Development

New Harvard consortium focuses on advanced bioproduction

The overarching mission of the collaboration is to catalyse the development of transformative therapies by shortening the path between research and clinical application
Research & Development

MIT researchers develop stretchable hydrogel electronics that deliver medicine to the skin

Water-based 'Band-Aid' can incorporate temperature sensors, LED lights, and other electronics
Research & Development

MIT researchers use ultrasound to improve drug delivery

New approach could aid in treatment of inflammatory bowel disease
Drug Delivery

New material opens possibilities for super-long-acting pills

A pH-responsive polymer gel could create swallowable devices, including capsules for ultra-long drug delivery
Research & Development

Pharma companies 'underinvest' in long-term cancer research, study finds

Tweaks to the R&D pipeline could create new drugs and greater benefit for patients
Subscribe now